Table 1.
Vaccines under consideration by platform and manufacturer/ developer, all stages from pre‐clinical; correct at 1st September 2020. See https://vac‐lshtm.shinyapps.io/ncov_vaccine_landscape/ for updates. Bold are in clinical trials
| Platform (vaccines in development) | Developer/ Manufacturer |
|---|---|
| RNA (30) | Arcturus, BIOCAD, BioNTech/Pfizer, Cansino, CNB‐CSIC, Chimeron Bio, China CDC, Chula VRC, CureVac, Elixirgen, Emergex Vaccines, eTheRNA, FBRI, Fudan University/ RNACure Biopharma, GeneOne, Gennova, Greenlight, IDIBAPS, Imperial College London/ VacEquity Global Health, Max Planck Institute, Moderna/ NIAID, People’s Liberation Army, RNAimmune, Rochester clinical research, Selcuk University, Translate Bio/ Sanofi, University of Tokyo, University of Washington, Ziphius |
| DNA (19) | Aegis, BioNet, Chula VRC, Ege University, Entos Pharmaceuticals, Genexine, Immunomic/ PharmaJet, Inovio, Karolinska Institute, Mediphage Bioceuticals, National Research Centre (Egypt), Osaka University/ AnGeS, Scancell, Statens Serum Institute, Takis, Touchlight Genetics, DIOSynVax/ Cambridge University, UW‐Madison, Zydus‐Cadila |
| Non‐replicating viral vector (29) | Altimmune, Ankara University, Bharat Biotech, CanSino, CNB‐CSIC, DZIF, Erciyes University, Gamaleya Research Institute, GeoVax, Greffex, ID Pharma, IDIBAPS, ImmunityBio, Janssen, AveXis, McMaster University, BIOTEC, National Research Centre (Egypt), ReiThera, Stabilitech, Tsinghua University, University of Georgia, University of Manitoba, University of Oxford/ AstraZeneca, Valo Therapeutics, Vaxart, Vaxinz. |
| Replicating Viral vector (21) | Aurobindo, Beijing Wantai Biological Pharmacy/ Xiamen University, BIOCAD, DZIF, FBRI, FIOCRUZ, IAVI/Merck, Institut Pasteur/Themis/Merck/University of Pittsburgh, Intravacc, Weizmann Institute, KU Leuven, Lancaster University, Sumagen, Tonix Pharma, University of Hong Kong, University of Western Ontario, UW‐Madison, Zydus Cadila. |
| Inactivated (14) | Sinopharm/ Beijing institute of biological products/ Wuhan institute of biological products, Beijing Minhai, Bharat Biotech, Erciyes University, Institute of Medical Biology/ Chinese Academy of Medical Sciences, KM Biologics, National Research Centre (Egypt), Osaka University, Research Institute for Biological Safety Problems, Selcuk University, Sinovac, Valneva. |
| Live Attenuated (4) | Codagenix/Serum Insitute India, Indian Immunologicals Ltd, Abicadem, Meissa |
| Protein (71) | AdaptVac, Adimmmune, AJ Vaccines, Akers Biosciences, Anhui Zhifei, AnyGo, Applied Biotechnology Institute, Axon Neuroscience, Baiya Phytopharm, Baylor Colloge, Biological E, BiOMVis, Bogazici, Chulalongkorn, Clover Biopharm/ GSK, Covaxx, EpiVax, ExpreS2ion, FBRI, Flow Pharma, G+Flas life science, Generex, Heat Biologics, Helix Biogen, iBio, ImmunoPrecise, IMV Inc, InnoMedica, Innovax, Instituto Finlay, Intravacc, Izmir Biomedicine, Kentucky Bioprocessing, LakePharma Inc, Liaoning Chengda, Lomonosov Moscow State University, Max Planck Institute, Medigen, MIGAL, MOGAM, Mynvax, Shionogi, National Research Centre (Egypt), Neovii, Oncogen, BIKEN, PDS Biotech, Quadram Institute, Research Institute for Biological Safety Problems, Sanofi/ GSK, Sichuan University, SK Biosciences, Soligenix, St Petersburg Scientific research institute of vaccines and sera, University of Alberta, UCSD, University of Pittsburgh, University of Queensland/ CSL/ Sequirus, CONICET, University of Virginia, Vabiotech, Vaxil Bio, Vaxine Pty, Versatope, VIDO‐InterVac, Walter Reed Army Institute of Research, Yisheng |
| VLP/ Nanoparticle (13) | ARTES, Bezmialem Vakif, Doherty Institute, Imophoron, IrsiCaixa, Mahidol University, Medicago/ GSK, Middle East Technical University, Novavax, Navvarabiomed, OSIVAX, Saiba, University of Sao Paolo, VBI Vaccines |
| Cell based (4) | Shenzhen Geno‐Immune Medical Institute, Henan Provincial centre for Disease Control and Prevention, Avita Biomed |
| Bacterial Vector (3) | Symvivo, UCLA, Versatope |